Press releases by members


7 November 2017
Nippon Chemiphar and SOM Biotech to Cooperate on New, Orphan Disease Indications for bevantolol (Calvan®) SOM Biotech SL
Nippon Chemiphar and SOM Biotech to Cooperate on New, Orphan Disease Indications for bevantolol (Calvan®) SOM Biotech has determined and validated an entirely new usage for Nippon Chemiphar’s marketed hypertension therapy bevantolol (Calvan®): Huntington's disease.
  View more
26 October 2017
Embryotools successfully concludes the first trials on an innovative assisted reproduction technique Parc Científic de Barcelona (PCB)
Embryotools successfully concludes the first trials on an innovative assisted reproduction technique
Embryotools—headquartered at Barcelona Science Park (PCB)— has successfully concluded tests on animal models to validate an innovative assisted reproduction technique known as Maternal Spindle Transfer (MST). The project has developed in partnership with the PCB-PRBB Animal Facility Alliance and the company Reprogenetics UK
  View more
26 October 2017
medmesafe, a new ehealth genetic analysis platform, has been launched medmesafe
medmesafe, a new ehealth genetic analysis platform, has been launched A new eHealth platform for genetic analysis and video consultation for private patients, is finally online, backed by an internationally recognized Ethical Committee.
  View more
17 October 2017
Omakase Consulting - Opening new office in Madrid Omakase Consulting, S.L.
As a consequence of its continuous growth, Omakase Consulting announces the opening of an office in Madrid from which, in conjunction with its Barcelona office, will continue to offer our strategic consultancy services in the areas of Evidence Generation, Multicriteria Decision Analysis (MCDA) and Pricing & Market Access.
Follow us on LinkedIn for more news
  View more
25 September 2017
VIVEbiotech´s CEO in the media: Gurutz Linazasoro, contribute his opinion about the biotechnology sector in Basque Country VIVEbiotech

Different Biotechnology Companies have actively participated in extended report from the Diario Vasco daily newspaper.
  View more
12 September 2017
Biosearch Life will be involved in the PREMIUM project, approved by European Commission Biosearch S.A.
Biosearch Life will be involved in the PREMIUM project, approved by European Commission The European Commission has recently announced the approval of the PREMIUM proposal: “Preservation of microorganisms by understanding the protective mechanisms of oligosaccharides”, submitted to the call: H2020-MSCA-RISE-2017.
  View more
11 September 2017
Sector Biofarmacéutico: Master Class CESIF Barcelona Centro de Estudios Superiores de la Industria Farmacéutica
Sector Biofarmacéutico: Master Class CESIF Barcelona El próximo día 20 de septiembre CESIF organiza en su sede de Barcelona una Master Class sobre el Sector Biofarmacéutico con la colaboración de ASBTEC (Asociación de Biotecnólogos de Cataluña).
  View more
2 August 2017
SOM Biotech licenses its first product and expands to the United States SOM Biotech SL
SOM Biotech licenses its first product and expands to the United States SOM Biotech has concluded a worldwide license agreement with Corino Therapeutics Inc. to clinically develop and market the drug SOM0226 against transthyretin amyloidosis (ATTR). The geographic expansion, and the clinical development of SOM’s most advanced assets, will be capitalized through the licensing revenues from SOM0226, as well as the commencing Series A fundraising.
  View more
24 July 2017
CESIF convoca el Programa Superior en Market Access Centro de Estudios Superiores de la Industria Farmacéutica
CESIF convoca el Programa Superior en Market Access El Programa aporta una visión global, multifuncional y completa sobre el Sector de la Salud que, en la actualidad, necesita Profesionales Expertos, conocedores de la realidad del Sistema Sanitario y de las herramientas necesarias para poder implementar Planes de Acceso eficaces.
  View more
13 July 2017
Life Sciences Newsletter nº4 Gómez-Acebo & Pombo Abogados, S. L. P.
At present, medical devices are regulated in the EU by three directives dating back to the 1990s: (a) Council Directive of 20 June 1990 on the approximation of the laws of the Member States relating to active implantable medical devices (90/385/EEC), (b) Council Directive 93/42/EEC of 14 June 1993 concerning medical devices...
  View more
13 July 2017
IDEN BIOTECHNOLOGY’S COMMITMENT FOR THE BIOTECHNOLOGY APPROACH TO SOCIETY Iden Biotechnology
IDEN BIOTECHNOLOGY’S COMMITMENT FOR THE BIOTECHNOLOGY APPROACH TO SOCIETY With the goal of approaching the biotechnology and its contribution in the agriculture to the society, along this year, Iden Biotechnology is carrying out different informative actions.
  View more
13 July 2017
CESIF convoca su primer Programa Superior en Digital Healthcare Business Centro de Estudios Superiores de la Industria Farmacéutica
CESIF convoca su primer Programa Superior en Digital Healthcare Business El Programa Superior en Digital Healthcare Business ha sido diseñado ad hoc para el Profesional de la Salud que desee especializarse en las nuevas formas de Marketing Digital aplicadas al entorno sanitario.
  View more
12 July 2017
CESIF convoca la IX Edición del PAE en "Desarrollo de Negocio y Licencias en la Industria Farmacéutica" en Barcelona Centro de Estudios Superiores de la Industria Farmacéutica
CESIF convoca la IX Edición del PAE en Tras el éxito de las ocho ediciones anteriores, el Centro de Estudios Superiores de la Industria Farmacéutica (CESIF) convoca en Barcelona este Programa Abierto de Especialización en “Desarrollo de Negocio y Licencias en la Industria Farmacéutica”.
  View more
11 July 2017
CESIF convoca la IV Edición del Programa Abierto de Especialización en "Project Management en Investigación Clínica" Centro de Estudios Superiores de la Industria Farmacéutica
CESIF convoca la IV Edición del Programa Abierto de Especialización en El Programa, consolidado por anteriores ediciones, está dirigido a profesionales vinculados al ámbito de la Investigación Clínica, tanto en Laboratorios Farmacéuticos, CROs, como Centros de Investigación con el fin de formarse para obtener la Certificación PMP®.
  View more
12 June 2017
Fundación para la Investigación Biomédica del Hospital Universitario La Paz
The event "La Paz 3.0: innovando para crecer" is organized by the Innovation Platform of the University Hospital La Paz.
  View more
2 June 2017
Launching of KeTLOD Project Knowledge Transfer in Organ Donation from Europe to China Parc Científic de Barcelona (PCB)
Launching of KeTLOD Project Knowledge Transfer in Organ Donation from Europe to China The University of Barcelona (UB) and the DTI Foundation, located at the Barcelona Science Park (PCB), are the main coordinators of the European project KeTLOD, an initiative of the European Union that aim to design the first postgraduate program in organ donation in China and to implement it in seven universities all over the country.
  View more
24 May 2017
SOM Biotech announces a worldwide license with Corino Therapeutics, Inc. for SOM0226, a drug for the treatment of TTR Amyloidosis. SOM Biotech SL
SOM Biotech announces a worldwide license with Corino Therapeutics, Inc. for SOM0226, a drug for the treatment of TTR Amyloidosis. SOM Biotech Ltd a leading clinical-stage biopharmaceutical company specialized in drug repurposing to treat rare diseases with a focus on CNS diseases, today announces an exclusive worldwide license agreement with U.S. based Corino Therapeutics, Inc. (Corino), for the clinical development and commercialization of SOM0226 (CRX-1008), a drug for the treatment of ATTR.
  View more
19 May 2017
Centro de Estudios Superiores de la Industria Farmacéutica
CESIF convoca la Máster Class enfocada en las salidas profesionales en la Industria Alimentaria el próximo día 7 de Junio en Barcelona
  View more
17 May 2017
Centro de Estudios Superiores de la Industria Farmacéutica
Jornada de Bioemprendedores enfocada en "El elefante Rosa"
  View more
4 May 2017
Los nuevos reglamentos de la Unión Europea sobre productos sanitarios Gómez-Acebo & Pombo Abogados, S. L. P.
Los nuevos reglamentos de la Unión Europea sobre productos sanitariosEn este documento se exponen los principales rasgos de los dos nuevos reglamentos de la Unión Europea sobre productos sanitarios, ya aprobados y pendientes de publicación en el Diario Oficial.
  View more
3 May 2017
Opening ceremony of the 15th edition of the Live Research Fair, Parc Científic de Barcelona (PCB)
Opening ceremony of the 15th edition of the Live Research Fair, Getting society closer to science, creating scientific vocation and making interaction easier between the audience and scientists are the main goals of the 15th edition of the Live Research Fair, which will take place in CosmoCaixa Barcelona from the 3rd to the 6th of May.
  View more
25 April 2017
Bionaturis out-licenses its Leishmaniasis vaccine for Argentina and Paraguay BIONATURIS GROUP
Bionaturis has signed an exclusive development, manufacturing, registration, and commercialization license of its Leishmaniasis vaccine with the company Biotandil for Argentina and Paraguay
According to the terms of the license, Bionaturis will receive 50% of the profits resulting of the commercialization.
  View more
20 April 2017
Life Sciences Newsletter nº3 Gómez-Acebo & Pombo Abogados, S. L. P.
As scientific evidence is insufficient to establish a cause and effect relationship between the consumption of Anxiofit-1 and the reduction of subthreshold and mild anxiety, Commission Regulation (EU) 2017/236 of 10 February 2017 refusing to authorise a health claim made on foods and referring to the reduction of disease risk refuses to...
  View more
29 March 2017
BIOKIT licenses CRISBIO™ technology to make high quality recombinant proteins for in vitro diagnostics for human use. ALGENEX (Alternative Gene Expression S.L.)
BIOKIT licenses CRISBIO™ technology to make high quality recombinant proteins for in vitro diagnostics for human use. BIOKIT and ALGENEX are extending their non-exclusive, commercial license agreement, to include also the CRISBIO™ technology for the manufacturing of recombinant proteins.
  View more
2 March 2017
Life Sciences Newsletter nº2 Gómez-Acebo & Pombo Abogados, S. L. P.
Published in OJ L 317, 23/11/2016, this Regulation establishes rules to determine the phytosanitary risks posed by any species, strain or biotype of pathogenic agents, animals or parasitic plants injurious to plants or plant products (‘pests’) and measures to reduce those risks to an acceptable level...
  View more
17 February 2017
Esteve and Enzymlogic join together to drive GPCR drug discovery Enzymlogic
Esteve and Enzymlogic join together to drive GPCR drug discovery Enzymlogic has entered into a research collaboration agreement with Esteve whereby Enzymlogic will direct its novel Binding Kinetics Platform to characterize selected compounds against mu-Opioid receptor.
  View more
8 February 2017
Future and Emerging Technologies- FET Infoday Fundación para la Investigación Biomédica del Hospital Universitario La Paz
On March 1, a infoday about the Future Emerging Technologies (FET) Horizon 2020 programme will take place in the IdiPAZ.
  View more
1 February 2017
Atrys Health and HM Hospital made an agreement to work on diagnostic kit ATRYS
Atrys Health and HM Hospital made an agreement to work on diagnostic kit The aim of the proyect is the development of a diagnostic kit for the implementation of a correct treatment on brain tumor, through liquid byopsy.
  View more
26 January 2017
SOM Biotech closes a €2M financing round SOM Biotech SL
SOM Biotech closes a €2M financing round SOM Biotech –a clinical-stage pharmaceutical company specialized in drug repositioning to treat rare diseases of the nervous system - has just closed a €2M financing round. The company will allocate this capital to boost its activities of internalization, co-development and licensing, as well as to finance a Ph2 of a drug for Huntington's, the 2nd asset of the company that reaches clinical stages.
  View more
16 January 2017
EPP eHealth Joint Statement of Unmet Needs launched Fundación para la Investigación Biomédica del Hospital Universitario La Paz
The European project EPP-eHealth has lauched its Joint Statement of Unmet Needs which presents the eHealth unmet needs identified by the four healthcare institutions involved in the project
  View more
12 January 2017
Sequentia launches AIR, a platform revolutionizing transcriptomics Parc Científic de Barcelona (PCB)
Sequentia launches AIR, a platform revolutionizing transcriptomics
Sequentia Biotech, based at the Barcelona Science Park, has launched a cloud computing platform called A.I.R. (Artificial Intelligence RNAseq), the first predictive bioinformatics tool that automatically analyzes mass transcriptomic data from the genome of any species, generated by the next generation sequencing technologies, providing a complete report in less than 24 hours.
  View more
Developed by Web4Bio